Is this you? Create Your Porfile
Avatar

Martin Knobloch

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Martin Knobloch is active.

Explore More

Publication

Featured researches published by Martin Knobloch.

Archive | 2010

FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER

Nathaniel D. Catron; Michael G. Fickes; Cristina M. Fischer; Rajeev Gokhale; Anthony R. Haight; Katherine Heemstra; David R. Hill; Martin Knobloch; Drazen Kostelac; Justin S. Lafountaine; Yanxia Li; Bernd Liepold; Kennan Marsh; Jonathan Mark Miller; Claudia Dr. Packhaeuser; Yeshwant Sanzgiri; Eric A. Schmitt; Yi Shi; Norbert Steiger; Ping Tong; Huailiang Wu; Geoff G. Z. Zhang; Deliang Zhou

Archive | 2007

Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor

Bernd Liepold; Joerg Rosenberg; Martin Knobloch; Christian Nehen

Archive | 2010

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

Claudia Packhaeuser; Norbert Steiger; Bernd Liepold; Drazen Kostelac; Martin Knobloch

Archive | 2007

Melt-processed imatinib dosage form

Joerg Breitenbach; Norbert Steiger; Harald Hach; Ulrich Westedt; Martin Knobloch; Ralf Altenburger; Nicoletta Loggia; Joerg Ogorka

Archive | 2008

Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics

Ulrich Westedt; Jörg Rosenberg; Martin Knobloch; Norbert Steiger; Harald Hach

Archive | 2012

Dosage form of Tyrosine Kinase Inhibitor for oral administration

Bernd Leipold; Joerg Rosenberg; Martin Knobloch; Christian Nehen

Archive | 2010

Forme posologique pharmaceutique pour l'administration orale d'un inhibiteur de la famille de bcl-2

Claudia Packhaeuser; Norbert Steiger; Bernd Liepold; Drazen Kostelac; Martin Knobloch

Archive | 2010

Pharmazeutische dosierungsform zur oralen verabreichung eines hemmers der bcl-2-familie

Claudia Packhaeuser; Norbert Steiger; Bernd Liepold; Drazen Kostelac; Martin Knobloch

Archive | 2010

Pharmaceutical dosage form for oral administration of an inhibitor of Bcl-2

Claudia Packhaeuser; Norbert Steiger; Bernd Liepold; Drazen Kostelac; Martin Knobloch

Archive | 2010

A pharmaceutical dosage form for oral administration of an inhibitor of the BCL-2 family

Claudia Packhaeuser; Norbert Steiger; Bernd Liepold; Drazen Kostelac; Martin Knobloch

Explore More

Collaboration

Dive into the Martin Knobloch's collaboration.

Top Co-Authors
Avatar

Norbert Steiger

Novartis

View shared research outputs
Top Co-Authors
Avatar

Harald Hach

Novartis

View shared research outputs
Top Co-Authors
Avatar

Ulrich Westedt

Novartis

View shared research outputs
Top Co-Authors
Avatar

Bernd Liepold

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Claudia Packhaeuser

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Joerg Rosenberg

Bosch

View shared research outputs
Top Co-Authors
Avatar

Jörg Breitenbach

Bosch

View shared research outputs
Top Co-Authors
Avatar

Nicoletta Loggia

Novartis

View shared research outputs
Top Co-Authors
Avatar

Ralf Altenburger

Novartis

View shared research outputs
Top Co-Authors
Avatar

Joerg Breitenbach

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge